An evolutionary explanation for the presence of cancer nonstem cells in neoplasms
Version of Record online: 26 NOV 2012
© 2012 The Authors. Evolutionary Applications published by Blackwell Publishing Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Special Issue: Evolution and Cancer
Volume 6, Issue 1, pages 92–101, January 2013
How to Cite
Sprouffske, K., Athena Aktipis, C., Radich, J. P., Carroll, M., Nedelcu, A. M. and Maley, C. C. (2013), An evolutionary explanation for the presence of cancer nonstem cells in neoplasms. Evolutionary Applications, 6: 92–101. doi: 10.1111/eva.12030
- Issue online: 21 JAN 2013
- Version of Record online: 26 NOV 2012
- Manuscript Accepted: 11 OCT 2012
- Manuscript Revised: 29 SEP 2012
- Manuscript Received: 16 JUL 2012
- National Institutes of Health . Grant Numbers: CA140657, HG000046, CA18029, CA144331, CA137811, CA91955, CA010815, CA119224
- the Natural Sciences and Engineering Research Council of Canada
- the Pew Charitable Trust
- the Martha W. Rodgers Charitable Trust
- a McLean Contributionship
- the Landon AACR Innovator Award for Cancer Prevention
- the American Cancer Society Research Scholar Grant. Grant Number: 117209-RSG-09-163-01-CNE
- 2007. Genetic progression and the waiting time to cancer. PLoS Computational Biology 3:e225. , , , , , , et al.
- 2001. Putting tumours in context. Nature Reviews Cancer 1:46–54. , and .
- 2010. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 466 13:3–7. , , , , , , et al.
- 1997. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine 3:730–737. , and .
- 1987. The Evolution of Individuality: Princeton University Press, Princeton, NJ.
- 1975. Mutation selection and the natural history of cancer. Nature 255:197–200. .
- 2001. Matrix population models, 2nd edn. Sinauer Associates,Sunderland, MA. .
- 2005. Induction of tumor growth by altered stem-cell asymmetric division in Drosophila melanogaster. Nature Genetics 37:1125–1129. , and .
- 2008. Preneoplastic lesion growth driven by the death of adjacent normal stem cells. Proceedings of the National Academy of Sciences of the United States of America 105:15034–15039. , , , , and .
- 2012. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488:522–526. , , , , , , and .
- 2009. The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell 138:1083–1095. , , , , , , et al.
- 2007a. (A)symmetric stem cell replication and cancer. PLoS Computational Biology 3:e53. , , and .
- 2007b. Compartmental architecture and dynamics of hematopoiesis. PLoS ONE 2:e345. , , and .
- 2007c. Stochastic dynamics of hematopoietic tumor stem cells. Cell Cycle 6:461–466. , , and .
- 2012. Defining the mode of tumour growth by clonal analysis. Nature 488:527–530. , , , , and .
- 2008. Waiting for two mutations: with applications to regulatory sequence evolution and the limits of Darwinian evolution. Genetics 180:1501–1509. , and .
- 2005. Statistical methods in bioinformatics: An introduction, 2nd ed: Springer, New York, NY. , and
- 2012. Clonal evolution in cancer. Nature 481:306–313. , and .
- 2006. A standard protocol for describing individual-based and agent-based models. Ecological Modelling 198:115–126. , , , , , , et al.
- 2009. Cancer stem cells: mirage or reality? Nature Medicine 15:1010–1012. , , and .
- 2000. The hallmarks of cancer. Cell 100:57–70. , and .
- 2011. Hallmarks of cancer: the next generation. Cell 144:646–674. , and .
- 2007. Tumor growth need not be driven by rare cancer stem cells. Science 317:337. , , , , and .
- 2005. Cancer, aging and the optimal tissue design. Seminars in Cancer Biology 15:494–505. .
- 1994. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367:645–648. , , , , , , et al.
- 2011. Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions. Cell Death Disease 2:e200. , , , , , , et al.
- 1965. The study of population growth in organisms grouped by stages. Biometrics, 21:1–18.
- 2010. Cancer stem cells: a reality, a myth, a fuzzy concept or a misnomer? An analysis. Carcinogenesis 31:149–158. , , , and .
- 1997. The Major Transitions in Evolution. Oxford University Press, USA. , and .
- 2006. Clonal expansion in the human gut: mitochondrial DNA mutations show us the way. Cell Cycle 5:808–811. , , , , , , et al.
- 2006. Cancer as an evolutionary and ecological process. Nature Reviews Cancer 6:924–935. , , , and .
- 2003. The linear process of somatic evolution. Proceedings of the National Academy of Sciences of the United States of America 100:14966–14969. , , and .
- 1976. The clonal evolution of tumor cell populations. Science 194:23–28. .
- 2007. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445:106–110. , , , and .
- 2010. Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. Journal of Clinical Investment 120:636–644. , , , , and .
- 2007. Animal cell differentiation patterns suppress somatic evolution. PLoS Computational Biology 3:e250. , , and .
- 2010. Microenvironmental modulation of asymmetric cell division in human lung cancer cells. Proceedings of the National Academy of Sciences of the United States of America 107:2195–2200. , , , , and .
- 2008. Efficient tumour formation by single human melanoma cells. Nature 456:593–598. , , , , , and .
- 2010. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141:583–594. , , , , , , et al.
- 2009. The increasing complexity of the cancer stem cell paradigm. Science 324:1670–1673. , and .
- 2011. Epithelial cell polarity: a major gatekeeper against cancer? Cell Death and Differentiation 18:1470–1477. , and .
- 2011. Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice. Journal of Clinical Investment 121:384–395. , , , , , , et al.
- 2012. Lineage tracing reveals Lgr5 + stem cell activity in mouse intestinal adenomas. Science 337:730–735. , , , , , , and .
- 2007. Molecular definition of breast tumor heterogeneity. Cancer Cell 11:259–273. , , , , , , et al.
- 2010.Exploring cancer stem cell niche directed tumor growth. Cell Cycle 9:1472–1479. , , , and .
- 2008. Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood 112:568–575. , , , , , , et al.
- 2010. Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction. Blood 115:1976–1984. , , , , , , et al.
- 2012. Cancer Stem Cells: Current Status and Evolving Complexities. Cell Stem Cell 10:717–728. , and .